0001209191-23-005351.txt : 20230127 0001209191-23-005351.hdr.sgml : 20230127 20230127182039 ACCESSION NUMBER: 0001209191-23-005351 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221114 FILED AS OF DATE: 20230127 DATE AS OF CHANGE: 20230127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neuman Linda L CENTRAL INDEX KEY: 0001951205 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 23564712 MAIL ADDRESS: STREET 1: C/O AEGLEA BIOTHERAPEUTICS, INC. STREET 2: 805 LAS CIMAS PARKWAY, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-14 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001951205 Neuman Linda L C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN TX 78746 0 1 0 0 Chief Medical Officer Employee Stock Option (right to buy) 1.36 2022-11-14 4 A 0 25000 0.00 A 2032-11-13 Common Stock 25000 25000 D The stock options will vest as to 1/4th of the total shares on November 14, 2023, and then 1/48th of the shares will vest monthly thereafter, such that the option will become fully vested on November 14, 2026, subject to the Reporting Person's provision of service to the issuer on each vesting date. /s/ James Kastenmayer, by power of attorney 2023-01-27